Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual Africans
Authors:
- Nathan ClumeckNCNathan Clumeck
- Marjorie Robert-GuroffMRMarjorie Robert-Guroff
- Philippe Van De PerrePPPhilippe Van De Perre
- Andrea JenningsAJAndrea Jennings
- Jean SibomanaJSJean Sibomana
- Patrick DemolPDPatrick Demol
- Sophie CranSCSophie Cran
- Robert C. GalloRGRobert C. Gallo
- 8 November 1985
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 254 (18) , 2599-2602
Abstract
Research from JAMA — Seroepidemiological Studies of HTLV-III Antibody Prevalence Among Selected Groups of Heterosexual AfricansKeywords
This publication has 10 references indexed in Scilit:
- Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire.BMJ, 1985
- Evidence for Exposure to HTLV-III in Uganda Before 1973Science, 1985
- HTLV-III SEROLOGY DISTINGUISHES ATYPICAL AND ENDEMIC KAPOSI'S SARCOMA IN AFRICAThe Lancet, 1985
- Lymphadenopathy-Associated Viral Antibody in AIDSNew England Journal of Medicine, 1984
- ACQUIRED IMMUNODEFICIENCY SYNDROME IN A HETEROSEXUAL POPULATION IN ZAIREThe Lancet, 1984
- Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDSScience, 1984
- AFRICAN KAPOSI'S SARCOMA AND AIDSThe Lancet, 1984
- Acquired Immunodeficiency Syndrome in African PatientsNew England Journal of Medicine, 1984
- Acquired Immunodeficiency Syndrome (AIDS) Associated with TransfusionsNew England Journal of Medicine, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983